Cognizant recently announced its collaboration with Gilead Sciences to expand their partnership. They will leverage machine ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Working to provide neuro acceleration in the AI space is Cognizant. Essentially a global ... human intervention towards defined goals while learning as they go so that they become more adept ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

Free cash flow increased to $837 million from $659 million, marking a substantial rise. Cognizant Technology Solutions experienced a robust fourth quarter, surpassing both analyst estimates and ...

Feb 5 (Reuters) - Cognizant Technology Solutions (CTSH.O), opens new tab forecast annual revenue below estimates on Wednesday, as uncertainty about the path of future interest rate cuts forces ...

CEO of Cognizant. "Enterprises are balancing the ... the purchasing journey in three pivotal phases in the years to come: Learn (when consumers learn about new products), Buy (when consumers ...

Leveraging machine learning and generative AI within an agentic ... Gilead is expected to enhance its efficiency through leveraging Cognizant's expertise in AI and advanced technology applications.

Ladies and gentlemen, welcome to the Cognizant Technology Solutions' Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...